Corona Remedies will make its market debut on Monday after its initial public offering drew strong interest from investors, subscribing 137 times during the December 8–10 bidding period.

The Rs 655-crore issue earlier garnered Rs 195 crore from anchor investors. The company had set a price band of Rs 1,008–1,062 per share.

Market analysts expect the stock to list with solid gains.

According to platforms tracking the grey market activities, the shares of Corona Remedies are commanding a GMP between 27-30 percent. Investorgain quoted a GMP of Rs 321 for the shares of the company, indicating a listing gain of 30.23 percent. Meanwhile, IPO Watch quoted a GMP of 27 percent.

Check All IPO News

Shivani Nyati, Head of Wealth at Swastika Investmart, said the shares are likely to debut at a pr

See Full Page